Global Markets
Oracle's $7 Billion Defense Deal Shakes Stock Outlook
724FinanceGökberk Uçar
Oracle (ORCL) shares have thrust back into the spotlight after sealing a $7 billion 10‑year software licensing agreement with the U.S. Department of Defense.
Scope of the Defense Contract
Stock Performance and Technical Indicators
Valuation and Return Outlook
Gökberk Uçar – This massive defense contract broadens Oracle’s revenue base while offsetting the risk of its recent AI‑heavy capital expenditures. The oversold RSI and solid dividend yield suggest a short‑term bounce and a medium‑term growth trajectory. Portfolio managers should consider scaling into ORCL if the price can sustain above the $250 target range.